期刊
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
卷 420, 期 2, 页码 293-296出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2012.02.152
关键词
Cdc25A; NF-kappa B; I kappa-B alpha; Ubiquitination; Apoptosis
资金
- National Research Foundation of Korea(NRF)
- Ministry of Education, Science and Technology [2009-0072203]
- National Research Foundation of Korea [2009-0072203] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
Cell division cycle 25A (Cdc25A), a dual specificity protein phosphatase, exhibits anti-apoptotic activity, but the underlying molecular mechanisms are poorly characterized. Here we report that Cdc25A inhibits cisplatin-induced apoptotic cell death by stimulating nuclear factor-kappa B (NF-kappa B) activity. In HEK-293 cells, Cdc25A decreased protein level of inhibitor subunit kappa B alpha (I kappa-B alpha) in association with increased serine 32-phosphorylation, followed by stimulation of transcriptional activity of NF-kappa B. Inhibition of NF-kappa B activity by chemical inhibitor or overexpression of I kappa-B alpha in Cdc25A-elevated cancer cells resistant to cisplatin improved their sensitivity to cisplatin-induced apoptosis. Our data show for the first time that Cdc25A has an important physiological role in NF-kappa B activity regulation and it may be an important survival mechanism of cancer cells. (C) 2012 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据